Production of helper‐dependent adenovirus vector relies on helper virus structure and complementing

Journal of Gene Medicine - Tập 4 Số 5 - Trang 498-509 - 2002
Huiyun Zhou1,2,3, Tiejun Zhao1, Xiao‐Mei Rao1, Arthur L. Beaudet2
1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA
2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
3Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA

Tóm tắt

AbstractBackgroundThe helper‐dependent (HD) adenoviral (Ad) vector relies on a helper virus to provide viral proteins for vector amplification. HD‐Ad vectors can significantly increase therapeutic gene expression and improve safety. However, the yield of an HD‐Ad vector is generally lower than that of an E1‐deleted first‐generation vector, likely due to the alterations in viral E3 or packaging regions of a helper virus that attenuate its replication and complementing for an HD‐Ad vector.MethodsTo study this question and improve HD‐Ad vector production, we have generated four different helper viruses with a wild‐type or deleted E3 region, and with a relocated loxP. We have also constructed a first‐generation vector with a wild‐type E3 region and without the loxP site. We compared the replication of these viruses in Cre‐positive and ‐negative cells and studied their complementing for HD‐Ad vector production.ResultsViruses with deleted E3 formed smaller plaques and produced lower titer compared with viruses containing the E3 region. The site where a loxP is inserted can also affect virus replication. Higher yield of HD‐Ad vector was obtained when a helper virus with wild‐type E3 was used. We also showed that deletion of the packaging signal in a helper virus through loxP/Cre interaction decreased the viral DNA complementing ability.ConclusionsAlthough the E3 region is not essential for adenovirus replication in vivo, deletion of this region attenuates virus replication. Production of HD‐Ad vector can be further improved by modifications in helper virus structure. Copyright © 2002 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

10.1038/sj.gt.3300928

10.1126/science.286.5448.2244

10.1128/jvi.70.11.7498-7509.1996

10.1073/pnas.89.7.2581

10.1128/JVI.72.2.926-933.1998

Lusky M, 1998, In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted, J Virol, 72, 2022, 10.1128/JVI.72.3.2022-2032.1998

Zhou H, 1996, Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted, J Virol, 70, 7030, 10.1128/jvi.70.10.7030-7038.1996

10.1006/viro.2000.0515

Gorziglia M, 1996, Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy, J Virol, 70, 4173, 10.1128/jvi.70.6.4173-4178.1996

Rittner K, 1997, Conditional repression of the E2 transcription unit in E1‐E3‐deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro, J Virol, 71, 3307, 10.1128/jvi.71.4.3307-3311.1997

Fang B, 1996, Lack of persistence of E1‐recombinant adenoviral vectors containing a temperature‐sensitive E2A mutation in immunocompetent mice and hemophilia B dogs, Gene Ther, 3, 217

10.1089/hum.1997.8.10-1275

10.1038/sj.gt.3301027

10.1073/pnas.92.9.3854

10.1073/pnas.93.12.5731

10.1007/BF02369439

10.1073/pnas.93.24.13565

10.1073/pnas.97.3.1002

10.1128/JVI.73.10.8027-8034.1999

10.1006/mthe.2001.0288

10.1089/hum.1998.9.18-2709

10.1073/pnas.95.14.7866

10.1038/ng0298-180

10.1006/mthe.2000.0104

10.1073/pnas.96.2.355

10.1073/pnas.94.5.1645

10.1093/hmg/5.7.913

10.1089/104303401750061249

10.1089/10430349950016807

10.1016/S1357-4310(98)01376-8

10.1034/j.1399-0004.2000.580101.x

10.1099/0022-1317-36-1-59

10.1006/viro.1997.8597

10.1073/pnas.91.19.8802

10.1007/BF02789331

10.1385/0-89603-178-0:109

10.1016/0042-6822(68)90121-9

Shenk T, 2001, Fields Virology, 2265

10.1006/viro.1996.0295

10.1128/JVI.74.13.6147-6155.2000

10.1038/33712

10.1089/hum.1998.9.13-1909

10.1089/104303400750001417

10.1016/0092-8674(83)90012-0

Thông tin
Thông tin xuất bản

Journal of Gene Medicine

Tập 4 Số 5

498-509

Thông tin tác giả